Inari Medical Inc
NASDAQ:NARI

Watchlist Manager
Inari Medical Inc Logo
Inari Medical Inc
NASDAQ:NARI
Watchlist
Price: 79.97 USD Market Closed
Market Cap: 4.7B USD

During the last 3 months Inari Medical Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 1% over this period (open performance analysis).

The last transaction was made on Jan 6, 2025 by Hoffman William (Chief Financial Officer) , who sold 8.5m USD worth of NARI shares.

Last Transactions:
Hoffman William
Chief Financial Officer
$-8.5m
Hykes Andrew
Chief Technology Officer
$-132.5k
Hoffman William
Chief Financial Officer
$-172.6k
Tu Thomas
Chief Financial Officer
$-220k
Hoffman William
Chief Financial Officer
$-150.3k
Hoffman William
Chief Financial Officer
$-1.2m
Hoffman William
Chief Financial Officer
$-1.5m
Hill, Mitch C.
Chief Executive Officer
$-71.4k
Hykes Andrew
Chief Technology Officer
$-150k
Hoffman William
Chief Financial Officer
$-1.2m
Hill, Mitch C.
Chief Executive Officer
$-219.3k
Hykes Andrew
Chief Technology Officer
$-165.7k
Hoffman William
Chief Financial Officer
$-186.4k
Tu Thomas
Chief Financial Officer
$-192k
Tu Thomas
Chief Financial Officer
$-546.5k
Hill, Mitch C.
Chief Executive Officer
$-163k
Hykes Andrew
Chief Technology Officer
$-150.2k
Hoffman William
Chief Financial Officer
$-1m
Chambers Rebecca
Chief Commercial Officer
$-12k
Hoffman William
Chief Financial Officer
$-1.4m
Hill, Mitch C.
Chief Executive Officer
$-117.8k
Hykes Andrew
Chief Technology Officer
$-150k
Hoffman William
Chief Financial Officer
$-3m
Chambers Rebecca
Chief Commercial Officer
$-43.8k
Hoffman William
Chief Financial Officer
$-1.5m
Hill, Mitch C.
Chief Executive Officer
$-13.3k
Hoffman William
Chief Financial Officer
$-1.5m
Hoffman William
Chief Financial Officer
$-58k
Hill, Mitch C.
Chief Executive Officer
$-245.8k
Hoffman William
Chief Financial Officer
$-1.1m
Hill, Mitch C.
Chief Executive Officer
$-251.4k
Hoffman William
Chief Financial Officer
$-715.9k
View All Transactions

During the last 3 months Inari Medical Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 1% over this period (open performance analysis).

The last transaction was made on Jan 6, 2025 by Hoffman William (Chief Financial Officer) , who sold 8.5m USD worth of NARI shares.

Sold
0-3
months
0 USD
0
3-6
months
10.4m USD
3
6-9
months
4.4m USD
4
9-12
months
9.2m USD
4
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Inari Medical Inc
Insider Trading Chart

Inari Medical Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Inari Medical Inc
Last Insider Transactions

Global
Insiders Monitor

Inari Medical Inc
Glance View

Market Cap
4.7B USD
Industry
Health Care

Inari Medical Inc., nestled in the heart of Irvine, California, embarked on a mission to revolutionize the treatment for venous diseases with a sense of urgency and ingenuity. Founded in 2011, this medical device company has become a beacon of innovation in the healthcare sector, relentlessly focused on addressing the unmet needs in the treatment of venous thromboembolism (VTE) conditions, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). These life-threatening conditions impact millions globally, presenting a critical challenge that Inari aims to tackle head-on. Their pioneering spirit is showcased in their flagship devices—the FlowTriever and ClotTriever—designed to remove large clots with less risk compared to traditional, invasive surgical methods. By providing minimally invasive mechanical thrombectomy devices, Inari Medical has streamlined treatments to improve patient outcomes, ultimately reducing the burden on healthcare systems. Revenue streams at Inari are intrinsically tied to their innovative products, which are integral in modern therapeutic strategies for clot removal. The commercial success of FlowTriever and ClotTriever is driven by their effectiveness and safety profile, appealing to hospitals and medical professionals looking for advanced solutions to treat VTE. Inari's business model thrives on the sales and adoption of these devices, supported by robust clinical evidence that underpins their efficacy. With a blend of aggressive research and development, education programs for physicians, and a strategic global market expansion, Inari Medical is poised to continue growing in the med-tech sector. Their commitment to addressing large medical needs with cutting-edge solutions not only defines their financial blueprint but also underscores their dedication to transforming patient care across the globe.

NARI Intrinsic Value
33.61 USD
Overvaluation 58%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top